Skip to content

Released Aug 5, 2025, before the open

10-Q filed Aug 5, 2025, 36 days after period end · 0000950170-25-102384

Q2 2025 · 10-Q
Revenue$203.12M+2.3% vs Q2 2024+4.9% vs Q1 2025
Net Income-$14.08MN/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$0.36N/M vs Q2 2024N/M vs Q1 2025
Gross Profit$139,533,000+3.6%
Operating Income-$16,003,000N/M
Operating Cash Flowderived$11,639,000+29.6%
Free Cash Flowderived$4,530,000N/M
Margins · derived
Gross margin68.7%+0.9 pt vs Q2 2024
Operating margin-7.9%+4.7 pt vs Q2 2024
Net margin-6.9%+9.9 pt vs Q2 2024

What the release said

The release

Same quarter

MetricQ2 2025Q2 2024Q2 2023Q2 2022
Revenue$203.12M$198.62M$187.02M$118.07M
Net Income-$14.08M-$33.44M-$39.43M$2.49M
EPS Diluted-$0.36-$0.88-$1.07$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR